Dr. Moreno is the founder and CEO of Navega Therapeutics, a biotechnology company focused on developing gene therapies for chronic pain management and other neurological conditions. She obtained her PhD from the Bioengineering Department at the University of California, San Diego, where she worked on the platform that enables Navega’s innovative approach. She has published in top-tier scientific journals, and her contributions to the field have been recognized by multiple awards and grants, highlighting her commitment to advancing medical science and improving patient outcomes.